References
- Deckert T., Feldt-Rasmussen B., Borch-Johnsen K., Jensen T., Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The steno hypothesis. Diabetologia 1989; 32(4)219–226
- Mogensen C.E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes mellitus. N. Eng. J. Med. 1984; 310: 356–360
- Mathiesen E.R., Hommel E., Giese J., Parving H.H. Efficacy of captopril in postponing nephropathy in normotensive insulin-dependent diabetic patients with microalbuminuria. BMJ 1991; 303(6794)81–87
- Mogensen C.E. Renoprotective role of ACE inhibitors in diabetic nephropathy. Br. Heart J. 1994; S35–S45, Suppl.
- Tripathi K., Prakash J., Appaika D., Srivastava P.K. Pentoxifylline in management of proteinuria in diabetic nephropathy. Nephron 1993; 64(4)641–642
- Guerrero-Romero F., Rodriguez-Moran M., Paniagua-Sierra J.R., Garcia-Bulnes G., Salas-Ramirez M., Amato D. Pentoxifylline reduces proteinuria in insulin-dependent and non-dependent diabetic patients. Clin. Nephrol. 1995; 43(2)116–121
- Ward A., Clissold S.P. Pentoxifylline: a review of its pharmacokinetic properties, and its therapeutic efficacy. Drugs 1987; 34: 50–97
- Toth L., Szenasi P., Varsanyi M.N., Szilvasi I., Lehoczky E., Kammerer L., Romics L. Elevated levels of plasma and urine β-thromboglobulin or thromboxane-B2 as markers of real platelet hyperactivation in diabetic nephropathy. Hemostasis 1992; 22(6)334–339
- Ambrus J.L., Anain J.M., Anain S.M., Anain P.M., Anain J.M., Jr., Anain Stadler S., Mitchell P., Brobst J.A., Cobert B.L. Dose-response effects of pentoxifylline on erythrocyte filterability: clinical and animal model studies. Clin. Pharmacol. Ther. 1990; 48(1)50–57
- Ortiz A., Edigo J. Is there a role for specific anti-TNF strategies in glomerular diseases?. Nephrol. Dial. Transplant. 1995; 10(3)309–311
- Loftis L.L., Meals E.A., English B.K. Differential effects of pentoxifylline and interleukin-10 on production of tumor necrosis factor and inducible nitric oxide synthase by murine macrophages. J. Infect. Dis. 1997; 175: 1008–1011
- Angielski S., Jakubowski Z., Pawelczyk T., Piec G., Redlak M. Renal handling and metabolism of adenosine in diabetic rats. Contrib. Nephrol. 1989; 73: 52–57
- Solerte S.B., Adamo S., Viola C., Zambianchi E., Ferrari E. Pentoxifylline and arterial hypertension in diabetes mellitus: long-term results in randomized groups. Ric. Clin. Lab. 1985; 15(S1)515–526
- Frantz R.P., Edwards B.S., Olson L.J., Schwab M.K., Adams T.F., Textor S.C., Daly R.C., McGregor C.G., Rodeheffer R.J. Effects of pentoxifylline on renal function and blood pressure in cardiac transplant patients: a randomized trial. Transplantation 1997; 63(11)1607–1610
- Navarro J.F., Mora C., Rivero A., Gallego E., Chahin J., Macia M., Mendez M.L., Garcia J. Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effect of pentoxifylline administration. Am. J. Kidney Dis. 1999; 33(3)458–463